Nicotine Sublingual Tablet Mint (NSTM) + Marketed Nicotine Tablet
Pre-clinicalCompleted 0 watching 0 views this week💤 Quiet
23
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Tobacco Dependence
Conditions
Tobacco Dependence
Trial Timeline
Sep 1, 2007 → Nov 1, 2007
NCT ID
NCT01238627About Nicotine Sublingual Tablet Mint (NSTM) + Marketed Nicotine Tablet
Nicotine Sublingual Tablet Mint (NSTM) + Marketed Nicotine Tablet is a pre-clinical stage product being developed by Johnson & Johnson for Tobacco Dependence. The current trial status is completed. This product is registered under clinical trial identifier NCT01238627. Target conditions include Tobacco Dependence.
Hype Score Breakdown
Clinical
5
Activity
2
Company
10
Novelty
2
Community
1
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01238627 | Pre-clinical | Completed |
Competing Products
20 competing products in Tobacco Dependence